Study of HX044 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an experimental drug called HX044 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and helps shrink tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must be able to do most daily activities on your own (ECOG 0 or 1).
- Your cancer must be advanced and either stopped responding to standard treatments, or no standard treatment exists.
- You need a tumor that can be measured on scans (at least in the later part of the study).
- Your heart, lungs, liver, kidneys, and blood counts must be working well enough based on lab tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug (HLX48) in people with advanced or metastatic solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and how well it works.
This study tests a new drug called HX111 for people with advanced solid tumors or certain lymphomas that have not responded to standard treatments. The goal is to see if the drug is safe and effective against these cancers.
This trial tests a new drug called HLX42 for people with advanced solid tumors (including a type of lung cancer called NSCLC) who have no good treatment options left. The goal is to see if it's safe and if it can help shrink tumors.
This trial tests a new medication, HLX51, which may help the immune system fight cancer. It is for people with advanced solid tumors or lymphoma who have tried standard treatments without success or cannot receive them.
This trial tests a new drug called HRS-4508 for people with advanced or metastatic solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe, how the body processes it, and if it helps shrink tumors.
This trial tests a new drug called HLX43 for people with advanced or metastatic solid tumors that have not responded to standard treatments. It aims to find safe dosing and understand how the drug works in the body.
Hear when a new Advanced Solid Tumor Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.